THU0503 In-Vitro Supression of TH17 Responses in Inflammatory Arthritis Patients Using Small Molecule Ror-Gamma-T Inhibitors

Abstract

BackgroundIncreasing evidence implicates the type 17 immune axis in the pathogenesis of inflammatory arthritidies including ankylosing spondylitis (AS), and targeting of the pathway in AS has shown benefit in early...